title: Rhodococcus erythropolis encephalitis in patient receiving rituximab.
authors: Satish R
authors: SR
authors: Bagdure
authors: Mark A
authors: MA
authors: Fisher
authors: Michael E
authors: ME
authors: Ryan
authors: Faisal A
authors: FA
authors: Khasawneh
mesh_terms: D000193:Actinomycetales Infections / Q000175:diagnosis* / Q000382:microbiology; D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D008590:Meningoencephalitis / Q000175:diagnosis* / Q000382:microbiology; D008727:Methotrexate / Q000009:adverse effects; D012240:Rhodococcus / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D008727:Methotrexate